• Western blot analysis of lysates from K-562 cells, using LHFPL2 Rabbit polyclonal antibody (STJ114674) at 1:3000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Enhanced Kit. Exposure time: 90s.

Anti-LHFPL2 antibody (30-100) (STJ114674)

SKU:
STJ114674

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-LHFPL2 (30-100) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:1000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: LHFPL2
Gene ID: 10184
Uniprot ID: LHPL2_HUMAN
Immunogen Region: 30-100
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 30-100 of human LHFPL2 (NP_005770.1).
Immunogen Sequence: SADWLIGKARSRGGVEPAGP GGGSPEPYHPTLGIYARCIR NPGVQHFQRDTLCGPYAESF GEIASGFWQAT
Tissue Specificity Expressed in all tissues and cell lines examined except brain and peripheral blood leukocytes.
Function Plays a role in female and male fertility. Involved in distal reproductive tract development.
Protein Name Lhfpl Tetraspan Subfamily Member 2 Protein
Lipoma Hmgic Fusion Partner-Like 2 Protein
Database Links Reactome: R-HSA-114608
Cellular Localisation Membrane
Multi-Pass Membrane Protein
Alternative Antibody Names Anti-Lhfpl Tetraspan Subfamily Member 2 Protein antibody
Anti-Lipoma Hmgic Fusion Partner-Like 2 Protein antibody
Anti-LHFPL2 antibody
Anti-KIAA0206 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance